| Literature DB >> 29780546 |
Han-Peng Jiang1, Jun Xiong1, Fei-Long Liu1, Cheng-Jie Ma1, Xing-Lin Tang1, Bi-Feng Yuan1, Yu-Qi Feng1.
Abstract
DNA and RNA contain diverse chemical modifications that exert important influences in a variety of cellular processes. In addition to enzyme-mediated modifications of DNA and RNA, previous in vitro studies showed that pre-modified nucleoside triphosphates (NTPs) can be incorporated into DNA and RNA during replication and transcription. Herein, we established a chemical labeling method in combination with liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) analysis for the determination of endogenous NTPs in the mammalian cells and tissues. We synthesized 8-(diazomethyl)quinoline (8-DMQ) that could efficiently react with the phosphate group under mild condition to label NTPs. The developed method allowed sensitive detection of NTPs, with the detection limits improved by 56-137 folds. The results showed that 12 types of endogenous modified NTPs were distinctly determined in the mammalian cells and tissues. In addition, the majority of these modified NTPs exhibited significantly decreased contents in human hepatocellular carcinoma (HCC) tissues compared to tumor-adjacent normal tissues. Taken together, our study revealed the widespread existence of various modified NTPs in eukaryotes.Entities:
Year: 2018 PMID: 29780546 PMCID: PMC5941283 DOI: 10.1039/c7sc05472f
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1(A) Synthesis route of the labeling reagent of 8-DMQ. (B) Chemical labeling reaction of NTPs by 8-DMQ.
Fig. 2Extracted ion chromatograms of the 34 NTPs without labeling (A) or with 8-DMQ labeling (B) followed by LC-ESI-MS/MS analysis. 1, ATP; 2, dATP; 3, GTP; 4, dGTP; 5, CTP; 6, dCTP; 7, UTP; 8, TTP; 9, N6-meATP; 10, 7-meGTP; 11, ITP; 12, XTP; 13, N1-meATP; 14, 2-S-UTP; 15, 5-hmCTP; 16, 5-meCTP; 17, 5-medCTP; 18, 5-hmdCTP; 19, 2′-O-meATP; 20, 2′-O-me-GTP; 21, 5-cadCTP; 22, YTP; 23, 2′-O-me-ITP; 24, 5-meUTP; 25, 2′-O-meCTP; 26, 5-caseUTP; 27, N6-medATP; 28, N4-medCTP; 29, 2′-O-meYTP; 30, 2′-O-meUTP; 31, 5-fodCTP; 32, 5-foCTP; 33, O6-meGTP; and 34, N1-meGTP.
The limits of detection (LODs) of 8 canonical NTPs with and without 8-DMQ labeling by LC-ESI-MS/MS analysis under the optimized detection conditions
| Analytes | Unlabeled (LODs, fmol) | After labelling (LODs, fmol) | Detection limit improved (folds) |
| ATP | 33.6 | 0.6 | 56 |
| GTP | 46.2 | 0.6 | 77 |
| CTP | 104.0 | 1.3 | 80 |
| UTP | 411.0 | 3.0 | 137 |
| dATP | 17.2 | 0.4 | 43 |
| dGTP | 124.3 | 1.1 | 113 |
| dCTP | 58.2 | 0.6 | 97 |
| TTP | 44.5 | 0.5 | 89 |
Fig. 3Determination of 5-meCTP and 5-medCTP in 293T cells. The extracted ion chromatograms (left panel), precursor ion spectra (middle panel) and product ion spectra (right panel) of (A) 5-meCTP standard, (B) 5-meCTP detected in 293T cells, (C) 5-medCTP standard, and (D) 5-medCTP detected in 293T cells.
Fig. 4Contents of the measured modified NTPs in cultured cells. (A) 293T cells, (B) HeLa cells, and (C) Jurkat-T cells.
Fig. 5MS spectra of modified NTPs carrying a CD3 group detected in 293T cells upon D3-Met metabolomic isotope labeling. (A) CD3-1-meATP, (B) CD3-2′-O-meGTP, (C) CD3-2′-O-meATP, (D) CD3-5-meCTP, (E) CD3-5-medCTP, (F) CD3-7-meGTP, and (G) CD3-N6-meATP.
Fig. 6Quantification and statistical analysis of the contents of 12 modified NTPs in human HCC tissues and tumor-adjacent normal tissues.